Effects of Dapagliflozin Combined with Acarbose on Blood Glucose and Diabetic Autoantibodies Triple Term in Patients with T2DM/LAN Haiqing， XIE Daifa， ZHU Changdong.//Medical Innovation of China，2025，22(20)： 051-055

    [Abstract]Objective：To investigate the efects of Dapagliflozin combined with Acarbose on the blood glucose control effect and diabetic autoantibody triple term in patientswith type2 diabetes melitus (T2DM). Method： A total of 126 patients with T2DM admited to Ganzhou Municipal Hospital from August 2021 to June 2024 were selected and divided into two groups by simple random method，with 63 cases in each group.Both groups weretreated with Metformin oraly，the control group was treated with Acarbose，and the study group was treated with Dapagliflozin on the basis of the control group.Both groups were treated for12 weeks.The blood glucose control effct [2 h postprandial blood glucose (2 h PG)， glycosylated hemoglobin (HbAlc)，fasting plasma glucose (FPG)]，the positiverateof diabeticautoantibodytriple term [insulinautoantibody(IAA)，isletcellantibody (ICA)， glutamic aciddecarboxylaseantibody(GADA) ......